AbbVie (ABBV) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Current Ratio
Quick Ratio
Cash & Equivalents
Total Assets
Total Liabilities
Shareholders Equity
Asset Composition
Debt Structure
AbbVie (ABBV) quarterly earnings & revenue
AbbVie (ABBV) reported revenue of $15.00B for Q1 2026, up 12.4% year-over-year, with net income of $699.00M and diluted EPS of $0.39.
Over the last four reported quarters, AbbVie generated $62.82B in revenue and $3.64B in net income.
AbbVie's next earnings report is scheduled for July 31, 2026 before market open; analysts estimate EPS of $3.76.
AbbVie quarterly results
| Fiscal quarter | Revenue | Revenue YoY | Net income | EPS (diluted) |
|---|---|---|---|---|
| Q1 2026 | $15.00B | +12.4% | $699.00M | $0.39 |
| Q4 2025 | $16.62B | +10.0% | $1.82B | $1.02 |
| Q3 2025 | $15.78B | +9.1% | $186.00M | $0.10 |
| Q2 2025 | $15.42B | +6.6% | $938.00M | $0.53 |
| Q1 2025 | $13.34B | +8.4% | $1.29B | $0.72 |
| Q4 2024 | $15.10B | +5.6% | $-22.00M | $-0.02 |
| Q3 2024 | $14.46B | +3.8% | $1.56B | $0.88 |
| Q2 2024 | $14.46B | +4.3% | $1.37B | $0.77 |
AbbVie (ABBV) — frequently asked questions
When does AbbVie (ABBV) report earnings next?
AbbVie is expected to report earnings on July 31, 2026 before market open. Analysts estimate EPS of $3.76.
What was ABBV's revenue last quarter?
AbbVie reported revenue of $15.00B in Q1 2026, up 12.4% from the same quarter a year earlier.
What was ABBV's EPS last quarter?
AbbVie reported diluted EPS of $0.39 in Q1 2026.
Is AbbVie profitable?
AbbVie is currently profitable, with $3.64B in net income over the last four reported quarters.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW) · Novartis (NVS)